WHO ICTRP trial

A clinical study on immune mechanism of rheumatic diseases

ChiCTR2100043294 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2100043294
Public title A clinical study on immune mechanism of rheumatic diseases
Scientific title A clinical study on immune mechanism of rheumatic diseases
Primary sponsor The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Observational study
Phase 0
Countries China
Conditions Rheumatoid Arthritis, Osteoarthritis, Gouty Arthritis, Developmental Dysplasia of Hip
Interventions Rheumatoid Arthritis (joint effusion):N/A;Osteoarthritis (joint effusion):N/A;Gouty Arthritis (joint effusion):N/A;Rheumatoid Arthritis (synovium):N/A;Osteoarthritis (synovium):N/A;Developmental Dysplasia of Hip (synovium):N/A
Registration date Feb 9, 2021
Target size Rheumatoid Arthritis (joint effusion):15;Osteoarthritis (joint…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations